Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 25446844)

  • 1. Next-generation sequencing of salivary high-grade neuroendocrine carcinomas identifies alterations in RB1 and the mTOR pathway.
    Goyal B; Duncavage EJ; Martinez D; Lewis JS; Chernock RD
    Exp Mol Pathol; 2014 Dec; 97(3):572-8. PubMed ID: 25446844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Next generation sequencing of Cytokeratin 20-negative Merkel cell carcinoma reveals ultraviolet-signature mutations and recurrent TP53 and RB1 inactivation.
    Harms PW; Collie AM; Hovelson DH; Cani AK; Verhaegen ME; Patel RM; Fullen DR; Omata K; Dlugosz AA; Tomlins SA; Billings SD
    Mod Pathol; 2016 Mar; 29(3):240-8. PubMed ID: 26743471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous squamous and neuroendocrine carcinoma: genetically and immunohistochemically different from Merkel cell carcinoma.
    Pulitzer MP; Brannon AR; Berger MF; Louis P; Scott SN; Jungbluth AA; Coit DG; Brownell I; Busam KJ
    Mod Pathol; 2015 Aug; 28(8):1023-32. PubMed ID: 26022453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Absence of Merkel cell polyomavirus in primary parotid high-grade neuroendocrine carcinomas regardless of cytokeratin 20 immunophenotype.
    Chernock RD; Duncavage EJ; Gnepp DR; El-Mofty SK; Lewis JS
    Am J Surg Pathol; 2011 Dec; 35(12):1806-11. PubMed ID: 22067330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retinoblastoma gene mutations detected by whole exome sequencing of Merkel cell carcinoma.
    Cimino PJ; Robirds DH; Tripp SR; Pfeifer JD; Abel HJ; Duncavage EJ
    Mod Pathol; 2014 Aug; 27(8):1073-87. PubMed ID: 24406863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NOTCH, ASCL1, p53 and RB alterations define an alternative pathway driving neuroendocrine and small cell lung carcinomas.
    Meder L; König K; Ozretić L; Schultheis AM; Ueckeroth F; Ade CP; Albus K; Boehm D; Rommerscheidt-Fuss U; Florin A; Buhl T; Hartmann W; Wolf J; Merkelbach-Bruse S; Eilers M; Perner S; Heukamp LC; Buettner R
    Int J Cancer; 2016 Feb; 138(4):927-38. PubMed ID: 26340530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RB1 gene in Merkel cell carcinoma: hypermethylation in all tumors and concurrent heterozygous deletions in the polyomavirus-negative subgroup.
    Sahi H; Savola S; Sihto H; Koljonen V; Bohling T; Knuutila S
    APMIS; 2014 Dec; 122(12):1157-66. PubMed ID: 24735260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D.
    Simbolo M; Mafficini A; Sikora KO; Fassan M; Barbi S; Corbo V; Mastracci L; Rusev B; Grillo F; Vicentini C; Ferrara R; Pilotto S; Davini F; Pelosi G; Lawlor RT; Chilosi M; Tortora G; Bria E; Fontanini G; Volante M; Scarpa A
    J Pathol; 2017 Mar; 241(4):488-500. PubMed ID: 27873319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of Akt/mTOR/4E-BP1 pathway signal activation and mutations of PIK3CA in Merkel cell polyomavirus-positive and Merkel cell polyomavirus-negative carcinomas.
    Iwasaki T; Matsushita M; Nonaka D; Kuwamoto S; Kato M; Murakami I; Nagata K; Nakajima H; Sano S; Hayashi K
    Hum Pathol; 2015 Feb; 46(2):210-6. PubMed ID: 25466966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The spectrum of Merkel cell polyomavirus expression in Merkel cell carcinoma, in a variety of cutaneous neoplasms, and in neuroendocrine carcinomas from different anatomical sites.
    Ly TY; Walsh NM; Pasternak S
    Hum Pathol; 2012 Apr; 43(4):557-66. PubMed ID: 21940035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proceedings of the NASHNP Companion Meeting, March 18th, 2018, Vancouver, BC, Canada: Salivary Neuroendocrine Carcinoma-An Overview of a Rare Disease with an Emphasis on Determining Tumor Origin.
    Chernock RD; Duncavage EJ
    Head Neck Pathol; 2018 Mar; 12(1):13-21. PubMed ID: 29556963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EGFR and HER2-Akt-mTOR signaling pathways are activated in subgroups of salivary gland carcinomas.
    Suzuki S; Dobashi Y; Minato H; Tajiri R; Yoshizaki T; Ooi A
    Virchows Arch; 2012 Sep; 461(3):271-82. PubMed ID: 22828828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hotspot mutations in polyomavirus positive and negative Merkel cell carcinomas.
    Veija T; Sarhadi VK; Koljonen V; Bohling T; Knuutila S
    Cancer Genet; 2016; 209(1-2):30-5. PubMed ID: 26725423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Next-Generation Sequencing Panels Reveal Molecular Differences Between Merkel Cell Polyomavirus-Negative Merkel Cell Carcinomas and Neuroendocrine Carcinomas.
    Hartsough E; Mino-Kenudson M; Lennerz JK; Dias-Santagata D; Hoang MP
    Am J Clin Pathol; 2023 Apr; 159(4):395-406. PubMed ID: 36812363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rb loss is characteristic of prostatic small cell neuroendocrine carcinoma.
    Tan HL; Sood A; Rahimi HA; Wang W; Gupta N; Hicks J; Mosier S; Gocke CD; Epstein JI; Netto GJ; Liu W; Isaacs WB; De Marzo AM; Lotan TL
    Clin Cancer Res; 2014 Feb; 20(4):890-903. PubMed ID: 24323898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UV Signature Mutations Reclassify Salivary High-grade Neuroendocrine Carcinomas as Occult Metastatic Cutaneous Merkel Cell Carcinomas.
    Sun L; Cliften PF; Duncavage EJ; Lewis JS; Chernock RD
    Am J Surg Pathol; 2019 May; 43(5):682-687. PubMed ID: 30986802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of high-risk human papillomavirus and Rb/E2F pathway genomic alterations in mutually exclusive subsets of colorectal neuroendocrine carcinoma.
    Shamir ER; Devine WP; Pekmezci M; Umetsu SE; Krings G; Federman S; Cho SJ; Saunders TA; Jen KY; Bergsland E; Jones K; Kim GE; Kakar S; Chiu CY; Joseph NM
    Mod Pathol; 2019 Feb; 32(2):290-305. PubMed ID: 30237525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UV-Associated Mutations Underlie the Etiology of MCV-Negative Merkel Cell Carcinomas.
    Wong SQ; Waldeck K; Vergara IA; Schröder J; Madore J; Wilmott JS; Colebatch AJ; De Paoli-Iseppi R; Li J; Lupat R; Semple T; Arnau GM; Fellowes A; Leonard JH; Hruby G; Mann GJ; Thompson JF; Cullinane C; Johnston M; Shackleton M; Sandhu S; Bowtell DD; Johnstone RW; Fox SB; McArthur GA; Papenfuss AT; Scolyer RA; Gill AJ; Hicks RJ; Tothill RW
    Cancer Res; 2015 Dec; 75(24):5228-34. PubMed ID: 26627015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Merkel cell polyomavirus infection, large T antigen, retinoblastoma protein and outcome in Merkel cell carcinoma.
    Sihto H; Kukko H; Koljonen V; Sankila R; Böhling T; Joensuu H
    Clin Cancer Res; 2011 Jul; 17(14):4806-13. PubMed ID: 21642382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
    McCluggage WG; Kennedy K; Busam KJ
    Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.